| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.3 | 0.1 |